> Home > Scientific program
| DC1 Diabetic nephropathy (ICDM) | Thursday, 7 November 10:20~11:50 / Convention hall C Chair: Dong-Seop Choi |
 |
Eun Young Lee Soonchunhyang University, Korea |
 |
DC1-1 CCL2/CCR2 signaling in diabetic nephropathy |
 |
Kyu-Sang Park Yonsei University, Korea |
|
DC1-2 Role of mitochondrial ROS on podocyte injury under diabetic milieu |
 |
Hun Joo Ha Ewha Womans University, Korea |
|
DC1-3 Direct effect of fractalkine on ECM accumulation in diabetic kidneys |
| DC2 Mechanisms of cardiovascular injury in diabetes (ICDM & AASD) |
Thursday, 7 November 16:00~17:30 / Convention hall C Chair: Nigishi Hotta |
 |
Jin Ho Shin Hanyang University, Korea |
|
DC2-1 Diabetic cardiomyopathy; clinical implications |
 |
Lu Cai University of Louisville, USA |
|
DC2-2 Metallothionein protects diabetic cardiomyopathy: evidence, mechanisms and potential clinical application |
 |
Ryuichi Morishita Osaka University, Japan |
|
DC2-3 Role of angiotensin II—RANKL pathway in cardiovascular complication |
| DC3 Diabetes foot (ICDM & AASD) | Friday, 8 November 09:00~10:30 / Convention hall C Chair: Dong Ik Kim |
 |
Dong-Ik Kim Sungkyunkwan University, Korea |
|
DC3-1 Epidemiology of diabetic foot |
 |
Ki-Hyuk Park Catholic University of Daegu, Korea |
|
DC3-2 Diagnosis & treatment of diabetic vasculopathy |
 |
Seung-Kyu Han Korea University, Korea |
|
DC3-3 Management principal of diabetic foot ulcers |
 |
Jong Moon Kim Konkuk University, Korea |
|
DC3-4 Shoe modification for diabetic foot ulcer |
| DC4 Diabetic retinopathy (ICDM) | Friday, 8 November 15:00~16:30 / Convention hall C Chair: Hyun Shik Son |
 |
Timothy Kern Case Western Reserve University, USA |
|
DC4-1 Inflammatory basis of diabetic retinopathy |
 |
Dong Ho Park Kyungpook National University, Korea |
|
DC4-2 Treatments for diabetic retinopathy: a double-edged sword |
 |
In-Beom Kim The Catholic University of Korea, Korea |
|
DC4-3 Therapeutic targets in diabetic retinopathy: anti-angiogenesis, anti-inflammation and neuron protection |
| DC5 New targets for the treatment of atherosclerosis (ICDM & AASD) |
Saturday, 9 November 09:00~10:30 / Convention hall C Chair: Yong Soo Park |
 |
Han Joong Jo Emory University, USA |
|
DC5-1 Mechanosensitive microRNAs in endothelial inflammation and atherosclerosis |
 |
Gu Taek Oh Ewha Womans University, Korea |
|
DC5-2 Immune cells as a target for the treatment of atherosclerosis |
 |
Yu Wang University of Hong Kong, Hong Kong |
|
DC5-3 Targeting endothelial senescence for atherosclerosis treatment: an approach based on SIRT1 modification |
 |
Room 1010, Renaissance Tower Bldg 456, Gongdeok-dong, Mapo-gu, Seoul, 121-706 Korea Tel. +82-2-714-9064 / Fax. +82-2-714-9084 / diabetes@kams.or.kr 
|
 |
